248 related articles for article (PubMed ID: 23891341)
1. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract][Full Text] [Related]
2. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
Mikell JK; Klopp AH; Gonzalez GM; Kisling KD; Price MJ; Berner PA; Eifel PJ; Mourtada F
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e417-22. PubMed ID: 22436788
[TBL] [Abstract][Full Text] [Related]
3. SU-E-T-425: Impact of Model Based Dose Calculation Algorithm for Ir-192 Intracavitary Brachytherapy with Shielded Applicator.
Mikell J; Klopp A; Price M; Mourtada F
Med Phys; 2012 Jun; 39(6Part16):3802. PubMed ID: 28517225
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
5. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
6. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Kim RY; Shen S; Duan J
Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
[TBL] [Abstract][Full Text] [Related]
7. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
8. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
10. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
[TBL] [Abstract][Full Text] [Related]
11. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
[TBL] [Abstract][Full Text] [Related]
14. HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.
Wu CH; Liao YJ; Shiau AC; Lin HY; Hsueh Liu YW; Hsu SM
Sci Rep; 2015 Dec; 5():17863. PubMed ID: 26658746
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric analysis and preliminary clinical result of image-guided brachytherapy with or without hybrid technique for cervical cancer using VariSource titanium ring applicator with "Siriraj Ring Cap".
Dankulchai P; Lohasammakul S; Petsuksiri J; Nakkrasae P; Tuntipumiamorn L; Kakanaporn C; Chansilpa Y
Brachytherapy; 2017; 16(6):1199-1204. PubMed ID: 28807748
[TBL] [Abstract][Full Text] [Related]
16. A treatment planning study comparing HDR and AGIMRT for cervical cancer.
Wahab SH; Malyapa RS; Mutic S; Grigsby PW; Deasy JO; Miller TR; Zoberi I; Low DA
Med Phys; 2004 Apr; 31(4):734-43. PubMed ID: 15124990
[TBL] [Abstract][Full Text] [Related]
17. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
18. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
19. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
20. Rectum and bladder spacing in cervical cancer brachytherapy using a novel injectable hydrogel compound.
Damato AL; Kassick M; Viswanathan AN
Brachytherapy; 2017; 16(5):949-955. PubMed ID: 28619385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
